+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Alpha-2 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha-2 Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Aldose Reductase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Aldose Reductase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
CXCR4 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

CXCR4 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Cannabinoid Receptor Type 1 (CB1) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Cannabinoid Receptor Type 1 (CB1) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Glycan Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Glycan Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Diglyceride Acyltransferase (DGAT) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Diglyceride Acyltransferase (DGAT) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
GABAB Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

GABAB Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Farnesoid X Receptor (FXR) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Farnesoid X Receptor (FXR) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Aldosterone Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Aldosterone Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
5-HT1B Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT1B Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alpha Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Endothelin Receptor A (ETA) Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Endothelin Receptor A (ETA) Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sigma Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Sigma Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cannabinoid Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Cannabinoid Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Cannabinoid Receptor Type 2 (CB2) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Cannabinoid Receptor Type 2 (CB2) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mitochondrial Electron Transport Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Mitochondrial Electron Transport Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Angiotensin Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Angiotensin Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more